← Leaderboards
Hana Totary-Jain
University Of South Florida
$5,502,512
Attributed
$5,502,512
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $619.9K · FY2008–25$1M$750K$500K$250K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,502,512 · 4
By mechanism
R01$4,338,490 · 1
R00$738,330 · 1
K99$267,678 · 1
F32$158,014 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of South Florida
Same institution · by research overlap
- Yiqin Du$5,621,370
- Isabella Hetherington$116,842
- Hua Pan$2,102,027
Others in their field
Top investigators on “Cardiovascular Diseases”
- Chanza Baytop · Westat, Inc.$271,217,917
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$145,558,149
- Judith S. Currier · University Of California Los Angeles$143,001,230
- David M Nathan · Massachusetts Institute Of Technology$141,671,512
- John M Lachin · George Washington University$139,991,329
- Judith S Hochman · New York University School Of Medicine$112,514,057
Research focus
Cardiovascular DiseasesCoronary ArteriosclerosisCause Of DeathBlood VesselsPharmaceutical PreparationsRestenosisUntranslated RegionsEndothelial CellsRattusCardiovascular SystemMicrornasSafetyAffectCellsIncidenceCessation Of LifeInjuryPlayStentsHyperplasiaThrombosisGrowthSirolimusBase
Grant awards (18)
Cell-Selective Therapies for Coronary Artery Disease$486,044
R01 · FY2025 · HL · contact PI
Cell-Selective Therapies for Coronary Artery Disease$476,323
R01 · FY2024 · HL · contact PI
Cell-Selective Therapies for Coronary Artery Disease$486,044
R01 · FY2023 · HL · contact PI
Cell-Selective Therapies for Coronary Artery Disease$486,044
R01 · FY2022 · HL · contact PI
Cell-Selective Therapies for Coronary Artery Disease$535,285
R01 · FY2021 · HL · contact PI
MicroRNA-Based, Cell-Selective Therapy for Coronary Artery Disease$373,750
R01 · FY2019 · HL · contact PI
MicroRNA-Based, Cell-Selective Therapy for Coronary Artery Disease$373,750
R01 · FY2018 · HL · contact PI
MicroRNA-Based, Cell-Selective Therapy for Coronary Artery Disease$373,750
R01 · FY2017 · HL · contact PI
MicroRNA-Based, Cell-Selective Therapy for Coronary Artery Disease$373,750
R01 · FY2016 · HL · contact PI
MicroRNA Detargeting Novel Therapy for Coronary Artery Disease$243,201
R00 · FY2016 · HL · contact PI
MicroRNA-Based, Cell-Selective Therapy for Coronary Artery Disease$373,750
R01 · FY2015 · HL · contact PI
MicroRNA Detargeting Novel Therapy for Coronary Artery Disease$246,129
R00 · FY2015 · HL · contact PI
MicroRNA Detargeting Novel Therapy for Coronary Artery Disease$249,000
R00 · FY2014 · HL · contact PI
MicroRNA Detargeting Novel Therapy for Coronary Artery Disease$133,839
K99 · FY2012 · HL · contact PI
MicroRNA Detargeting Novel Therapy for Coronary Artery Disease$133,839
K99 · FY2011 · HL · contact PI
Regulation of Vascular Smooth Muscle Cell Proliferation$53,810
F32 · FY2010 · HL · contact PI
Regulation of Vascular Smooth Muscle Cell Proliferation$53,870
F32 · FY2009 · HL · contact PI
Regulation of Vascular Smooth Muscle Cell Proliferation$50,334
F32 · FY2008 · HL · contact PI